An international consensus statement on generalized pustular psoriasis (GPP) from the International Psoriasis Council (IPC) includes the recommendation that considerations such as body surface ...

A type found in skin folds such as the armpit, groin, beneath breasts, and buttocks. It appears as ... exposure to ultraviolet A (UVA) rays. Pustular psoriasis. A type with non-infectious, pus ...

buttocks, or scalp—that span at least a few centimeters. These plaques can be itchy, painful, or even bleed. Pustular psoriasis can bring on painful, pus-filled bumps on the skin that range in ...

Generalized pustular psoriasis (GPP) is a rare, life-threatening skin condition for which there are no approved treatments. It is characterized by episodes of widespread eruptions of painful ...

Fast Five Quiz: Generalized Pustular Psoriasis How much do you know about generalized pustular psoriasis? Assess your knowledge with this quick quiz. Medscape Reference, May 15, 2025 S3 Episode 4 ...

Generalized pustular psoriasis (GPP) is a rare, life-threatening, inflammatory skin disease characterized by widespread eruption of sterile pustules. Interleukin-36 signaling is involved in the ...

Generalized pustular psoriasis is a life-threatening disease of unknown cause. It is characterized by sudden, repeated episodes of high-grade fever, generalized rash, and disseminated pustules ...

Multiple Pustular Eruptions Alexandria Brown, BSA ; Shravya Pothula, BS ; Emily Burns, BA ; Christopher Rizk, MD Publish Date June 29, 2020 ...

"Vanda and AnaptysBio link for generalised pustular psoriasis therapy" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has ...

Spevigo (spesolimab) reduced the risk for generalized pustular psoriasis flares by 84% over 48 weeks. Spevigo’s safety profile was comparable to placebo. Spevigo significantly outperformed ...

The FDA has approved the monoclonal antibody spesolimab (Spevigo) as the first treatment for generalized pustular psoriasis (GPP), Boehringer Ingelheim announced. The approval stipulates use of ...